MedPath

A study to compare two drugs

Not Applicable
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Registration Number
CTRI/2024/07/071524
Lead Sponsor
Anusha Jose
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 1 &11

Patients for elective surgery under GA

Exclusion Criteria

Allergic to propofol.Ketamine or Fentanyl

H/o DM,CAD,HTN

Patients on psychotropic drugs

Pregnant women

Any known CNS disorder

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Ketamine reduces the effect site concentration of propofol when compared tp fentanyl in relation to loss of consciousness and pain during induction of anaesthesiaTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
nilTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath